Infrared Research
The fabric is soft. The standards are not.
CELLIANT® is infrared textile technology backed by two decades of clinical, preclinical, physical, and technical research. Across numerous peer-reviewed, published studies, researchers have examined CELLIANT textiles in relation to biomarkers like local circulation and tissue oxygenation.
We do not believe wellness should be vague. That is why we study measurable outcomes, publish the work, and keep asking better questions—so you can understand the technology built into the things you use every day and every night.
Research has included work with the University of Notre Dame, University of Texas Southwestern Medical Center, University of California, Irvine, and Veterans Affairs Long Beach Healthcare System.
Research institutions
The research
CELLIANT Studies
The body of research below collectively demonstrates the efficacy of CELLIANT technology. Every study below looks at a specific question in a specific population, under specific conditions to help build the collective understanding. Read the studies in full, explore the outcomes, and decide what the science means for you.
-
2025 Post-exercise recoveryA Preliminary Investigation of the Efficacy of Far-Infrared-Emitting Garments in Enhancing Objective and Subjective Recovery Following Resistance Exercise*Conducted at University of Notre Dame
What they measured
jump height, takeoff velocity, and Modified Reactive Strength Index after resistance exercise.
Published in the Journal of Functional Morphology and Kinesiology
*This study was conducted by KYMIRA, a licensed CELLIANT brand partner. Hologenix had no role in study design, data collection, or interpretation of results.
-
2022 Peripheral blood flow in vascular impairmentRandomized Placebo-Controlled Clinical Trial of Gloves and Stockings Made from Infrared-Emitting Fabric (CELLIANT®) for Transcutaneous Oxygen and Peripheral Blood Flow in Diabetic Patients with Vascular ImpairmentConducted at University of Texas Southwestern Medical Center
What they measured
tissue oxygen levels and peripheral blood flow in patients with diabetes-related vascular impairment.
Published in the Journal of Textile Science & Engineering
-
2021 Grip strengthEffect of CELLIANT® Armbands on Grip Strength in Subjects with Chronic Wrist and Elbow PainConducted at Veterans Affairs Long Beach Healthcare System
What they measured
grip strength in adults with chronic wrist and elbow pain.
Published in the Research Journal of Textile and Apparel
-
2019 Grip strengthEffect of Shirts with 42% CELLIANT Fiber on TcPO2 Levels and Grip Strength in Healthy Subjects: A Placebo-Controlled Clinical TrialConducted at Veterans Affairs Long Beach Healthcare System
What they measured
tissue oxygen and grip strength in healthy adults.
Published in the Journal of Textile Science and Engineering
-
2018 Tissue oxygen (TcPO2)Randomized Controlled Trial Comparing the Effects of Far-Infrared Emitting Ceramic Fabric Shirts and Control Polyester Shirts on Transcutaneous PO2Conducted at Veterans Affairs Long Beach Healthcare System
What they measured
tissue oxygen levels after 90 minutes of CELLIANT shirt wear, compared to a control polyester shirt.
Published in the Journal of Textile Science and Engineering
-
2012 Tissue oxygen (TcPO2)The Test Report on the Impacts of Subject Socks with the Application of CELLIANT Technical Fibers on Transcutaneous Oxygen Pressure on a Man's FootConducted at China Academy of Chinese Medical Sciences
What they measured
tissue oxygen pressure in the foot during sock wear.
-
2012 Tissue oxygen, vasoactive effectTranscutaneous Partial Pressure of Oxygen (tcPO2) as a Primary Endpoint to Assess the Efficacy of CELLIANT as a Vasoactive MaterialConducted at Veterans Affairs Long Beach Healthcare System
What they measured
tissue oxygen as a primary endpoint to assess CELLIANT's vasoactive (local circulation-promoting) properties.
-
2011 Performance and recoveryApparel with Far Infrared Radiation for Decreasing an Athlete's Oxygen Consumption During Submaximal ExerciseConducted at University of Calgary
What they measured
oxygen consumption (VO2) and anaerobic threshold in elite and club-level cyclists during submaximal exercise.
Published in the Research Journal of Textile and Apparel
-
2010 Sleep pilotDouble Blind, Placebo Controlled, Crossover Trial on the Effect of Optically Modified Polyethylene Terephthalate Fiber Mattress Covers on Sleep Disturbances in Patients with Chronic Back PainConducted at University of California, Irvine
What they measured
nighttime awakenings, sleep quality, and sleep efficiency in adults with chronic back pain sleeping on CELLIANT mattress covers.
-
2009 Foot pain in diabetic neuropathyEffect of Optically Modified Polyethylene Terephthalate Fiber Socks on Chronic Foot PainConducted at University of California, Irvine
What they measured
chronic foot pain and comfort in subjects with diabetic foot neuropathy.
Published in the BioMed Central Complementary & Alternative Medicine
-
2005 Early tissue oxygen findingsHolofiber Study of Thirteen (13) Healthy SubjectsConducted at Texas A&M University
What they measured
tissue oxygen levels in healthy subjects wearing the early predecessor fiber to today's CELLIANT.
Beyond the clinical trials
Clinical research is one part of the CELLIANT story. Preclinical, physical, and technical studies examine the material science beneath it: how natural bioceramic minerals interact with infrared energy and how the technology performs in laboratory settings.
Meet the experts:
Understand the science:
Try it yourself:
Frequently Asked Questions
No, CELLIANT® is not FDA approved.
Based on the information submitted in accordance with section 513(g) of the Federal Food, Drug, and Cosmetic Act (Act), the U.S. Food and Drug Administration (FDA) has determined that CELLIANT® products, containing infrared emitting ceramic particles, are medical devices as defined in section 201(h) of the Act, and are general wellness products. The FDA has not approved or designated CELLIANT products for any purpose and has not made any determination about, or endorsement of, its stated use or benefits.
General wellness products are low-risk consumer technologies overseen by the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) that don’t require medical device regulation because they only promote a healthy lifestyle or general state of well-being. The purpose of a general wellness product is to maintain or encourage a general state of health and a healthy lifestyle and they may also help to reduce the risk or impact of certain chronic conditions only where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for these conditions. CELLIANT® products do not claim to diagnose, cure, mitigate, prevent, or treat any specific medical condition or disease.
CELLIANT® is biocompatible and completely safe for human contact. The infrared emitting ceramic particles used in the fabric have undergone rigorous independent testing to ensure they do not cause adverse biological reactions when interacting with the human body. Allergic reactions to any materials can occur, however, there have been no reported cases of allergic reactions since CELLIANT products became available in 2003.